Synergy Pharmaceuticals Logo Image

Synergy Pharmaceuticals

Most Recent Annual Report

2017 Annual Report and Form 10K

Synergy Pharmaceuticals

Synergy Pharmaceuticals has reached its limit for free report views.

Synergy Pharmaceuticals does not currently have any hardcopy reports on Click the button below to request a report when hardcopies become available.

Archived Annual Reports

About Synergy Pharmaceuticals

51-200 Employees
Based in New York City, New York

Synergy is a biopharmaceutical company focused on the development and commercialization of novel GI therapies. The company has pioneered discovery, research and development efforts around uroguanylin analogs for the treatment of functional GI disorders and inflammatory bowel disease. Synergy’s proprietary GI platform is based on uroguanylin and includes two lead product candidates – plecanatide and dolcanatide.

NASDAQ (See More NASDAQ Companies)
Drug Manufacturers - Other (See More Drug Manufacturers - Other Companies)
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol